For people living with aggressive blood cancers, CAR T-cell therapy offers hope for a longer, healthier life, and for some, the opportunity for cure. Yet currently only ~2 out of 10 people in the US and ~3 out of 10 people in Europe with advanced blood cancers get access to CAR T. To address barriers […]
The post New CAR T Vision Coalition and roadmap report to launch at ASCO aims to double patients treated with CAR T-cell therapy by 2030 appeared first on Pharmafile.
